The IL-8 pathway was reported to be important in cancer [36] and CX3CL1 expression was associated with a poor outcome in breast cancer patients [37] as it promotes breast cancer via transactivation of the epidermal growth factor pathway [38]. Here, CX3CL1 is linked to cancer.